NCT01149460

Valacyclovir 1000 mg Tablet Under Fed Conditions

Randomized, 2-Way Crossover, Bioequivalence Study of Valacyclovir 1000 mg Tablet and Valtrex Administered as 1 x 1000 mg Tablet in Healthy Subjects Under Fed Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Teva Pharmaceuticals USA · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of this study was to compare the rate and extent of absorption of Teva Pharmaceuticals USA valacyclovir and GlaxoSmithKline, USA (Valtrex) valacyclovir, administered as 1 x 1000 mg tablet under fed conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Valacyclovir	Test 1000 mg Tablet
DRUG	Valacyclovir	Reference Listed Valacyclovir 1000 mg Tablet

Timeline

• Start date: 2004-09-01
• Primary completion: 2004-09-01
• Completion: 2004-09-01
• First posted: 2010-06-23
• Last updated: 2024-08-21
• Results posted: 2010-09-14

Locations

1 site across 1 country: Canada